These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report. Cao M, Zhang S, Chu D, Xiao M, Liu X, Yu L, Li J, Huang Y, Fang F. BMC Pulm Med; 2020 Nov 19; 20(1):304. PubMed ID: 33213393 [Abstract] [Full Text] [Related]
8. Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review. McPherson M, Economidou S, Liampas A, Zis P, Parperis K. Semin Arthritis Rheum; 2022 Apr 19; 53():151959. PubMed ID: 35134633 [Abstract] [Full Text] [Related]
9. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies. Yamaguchi K, Yamaguchi A, Kashiwagi C, Sawada Y, Taguchi K, Umetsu K, Oshima K, Uchida M, Suzuki M, Kono S, Takemura M, Masubuchi H, Kitahara S, Hara K, Maeno T, Motegi SI, Muro Y, Sakairi T, Hisada T, Kurabayashi M. Respir Med; 2018 Jul 19; 140():1-5. PubMed ID: 29957268 [Abstract] [Full Text] [Related]
17. Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report. Kishi T, Tani Y, Okiyama N, Mizuochi K, Ichimura Y, Harigai M, Nagata S, Miyamae T. Pediatr Rheumatol Online J; 2021 Mar 19; 19(1):34. PubMed ID: 33740993 [Abstract] [Full Text] [Related]